Citation Impact
Citing Papers
Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma
2016
PD-L1 Expression in Melanocytic Lesions Does Not Correlate with the BRAF V600E Mutation
2014
The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins
2019 StandoutNobel
The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications
2011
Control of PD-L1 Expression by Oncogenic Activation of the AKT–mTOR Pathway in Non–Small Cell Lung Cancer
2015
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
2017 StandoutNature
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
SF3B1 deficiency impairs human erythropoiesis via activation of p53 pathway: implications for understanding of ineffective erythropoiesis in MDS
2018
CDK4 deficiency promotes genomic instability and enhances Myc-driven lymphomagenesis
2014
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
2016
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
MYC on the Path to Cancer
2012 Standout
A view on drug resistance in cancer
2019 StandoutNature
Inflammatory networks and immune surveillance of pancreatic carcinoma
2013
Combination cancer immunotherapy and new immunomodulatory targets
2015
Combining immunotherapy and targeted therapies in cancer treatment
2012
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer
2017 StandoutNobel
Combined Genetic Inactivation of β2-Microglobulin and CD58 Reveals Frequent Escape from Immune Recognition in Diffuse Large B Cell Lymphoma
2011
Glycosylation-Dependent Lectin-Receptor Interactions Preserve Angiogenesis in Anti-VEGF Refractory Tumors
2014
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
Ribosomal Protein Mutations Induce Autophagy through S6 Kinase Inhibition of the Insulin Pathway
2014
Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes
2018 StandoutNobel
Genetically engineered mouse models of cancer reveal new insights about the antitumor immune response
2013
Tumor-Associated Macrophages: From Mechanisms to Therapy
2014 Standout
Pancreatic Adenocarcinoma
2014 Standout
The Genetic Landscape of Diffuse Large B-Cell Lymphoma
2015
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer
2017 StandoutNobel
A Ribosomopathy Reveals Decoding Defective Ribosomes Driving Human Dysmorphism
2017 StandoutNobel
Translation of branched-chain aminotransferase-1 transcripts is impaired in cells haploinsufficient for ribosomal protein genes
2014
Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy
2013 Standout
Regulation and Function of the PD-L1 Checkpoint
2018 Standout
Molecular mechanisms of T cell co-stimulation and co-inhibition
2013 Standout
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
Antagonists of PD-1 and PD-L1 in Cancer Treatment
2015
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Analysis of the coding genome of diffuse large B-cell lymphoma
2011
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
2016 Standout
Diffuse large B-cell lymphoma—treatment approaches in the molecular era
2013
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
The cancerous translation apparatus
2011
Multiplexed immunohistochemistry, imaging, and quantitation: A review, with an assessment of Tyramide signal amplification, multispectral imaging and multiplex analysis
2014
The PI3K Pathway in Human Disease
2017 Standout
Cornerstones of CRISPR–Cas in drug discovery and therapy
2016 StandoutNobel
Shaping the Immune Landscape in Cancer by Galectin-Driven Regulatory Pathways
2016
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Quantitative Super-Resolution Microscopy of the Mammalian Glycocalyx
2019 StandoutNobel
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
2015 Standout
Glycosylation in cancer: mechanisms and clinical implications
2015 Standout
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
2018 Standout
Lack of immunoediting in murine pancreatic cancer reversed with neoantigen
2016
Identification and transcriptome analysis of erythroblastic island macrophages
2019 StandoutNobel
Coinhibitory Pathways in Immunotherapy for Cancer
2016
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
2018 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
2018 StandoutNobel
The role of B7 family molecules in hematologic malignancy
2012
The future of immune checkpoint therapy
2015 StandoutScienceNobel
Cancer Genome Landscapes
2013 StandoutScience
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
2015 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Galectins: Multitask signaling molecules linking fibroblast, endothelial and immune cell programs in the tumor microenvironment
2018
Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicities
2016 StandoutNobel
B cell–intrinsic TBK1 is essential for germinal center formation during infection and vaccination in mice
2021 StandoutNobel
IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
2017 Standout
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
2014 Standout
Adaptive Immune Resistance: How Cancer Protects from Immune Attack
2015
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Cancer immunotherapy using checkpoint blockade
2018 StandoutScience
Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity
2017 StandoutNobel
Unforeseen pathologies caused by malaria
2017
Works of Treeve Currie being referenced
Quantitative Immunofluorescence Reveals the Signature of Active B-cell Receptor Signaling in Diffuse Large B-cell Lymphoma
2012
Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells
2010
Integrative Analysis Reveals an Outcome-Associated and Targetable Pattern of p53 and Cell Cycle Deregulation in Diffuse Large B Cell Lymphoma
2012
Immune Surveillance and Therapy of Lymphomas Driven by Epstein-Barr Virus Protein LMP1 in a Mouse Model
2012
Viral induction and targeted inhibition of galectin-1 in EBV+ posttransplant lymphoproliferative disorders
2011
AP1-Dependent Galectin-1 Expression Delineates Classical Hodgkin and Anaplastic Large Cell Lymphomas from Other Lymphoid Malignancies with Shared Molecular Features
2008
Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma
2010